RNA repair: A novel approach to gene therapy

Advanced Drug Delivery Reviews

Volumn 44, Issue 2-3, 2000, Pages 109-118

  Watanabe, Takashi ^a,b   Sullenger, Bruce A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Gene therapy; Ribozyme; Splicing

Indexed keywords

PATIENT TREATMENT; RNA;

GENE THERAPY; RIBOZYME; SPLICING;

GENETIC ENGINEERING;

ANTISENSE OLIGONUCLEOTIDE; BASE; COMPLEMENTARY RNA; NUCLEOTIDE; OLIGOMER; RIBOZYME;

COVALENT BOND; GENE MUTATION; GENE TECHNOLOGY; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; HUMAN; INTRON; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA REPAIR; RNA SPLICING; TRANS SPLICING;

EID: 0034670090     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(00)00089-2     Document Type: Article

References (40)

1. Progress toward human gene therapy
2. Human gene therapy
3. The basic science of gene therapy
4. Messenger RNA splicing in yeast:clues to why the spliceosome is a ribonucleoprotein
5. Biochemical mechanisms of constitutive and regulated pre-mRNA splicing
6. RNA editing
7. Gene therapy - promises, problems and prospects
8. p53: the ultimate tumor suppressor gene?
9. Overexpression of wild-type p53 alters growth and differentiation of normal human keratinocytes but not human papillomavirus-expressing cell lines
10. Adenovirus-mediated gene transfer of the tumor suppressor, p53, induces apoptosis in postmitotic neurons
11. Toward the therapeutic editing of mutated RNA sequences
12. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase
13. Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides
14. Repair of thalassemic human β-globin mRNA in mammalian cells by antisense oligonucleotides
15. Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs
16. Two-step affinity purification of U7 small nuclear ribonucleoprotein particles using complementary biotinylated 2'-O-methyl oligoribonucleotides
17. Biochemical complementation with RNA in the Xenopus oocyte: a small RNA is required for the generation of 3' histone mRNA termini
18. The low abundance of U7 snRNA is partly determined by its Sm binding site
19. Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena
20. Self-splicing of group I introns
21. Autocatalytic cyclization of an excised intervening sequence RNA is a cleavage-ligation reaction
22. Fate of an intervening sequence ribonucleic acid: excision and cyclization of the Tetrahymena ribosomal ribonucleic acid intervening sequence in vivo
23. One binding site determines sequence specificity of Tetrahymena pre-rRNA self-splicing, trans-splicing, and RNA enzyme activity
24. Intermolecular exon ligation of the rRNA precursor of Tetrahymena: oligonucleotides can functions as 5' exons
25. Sequence-specific endoribonuclease activity of the Tetrahymena ribozyme:enhanced cleavage of certain oligonucleotide substrates that form mismatched ribozyme-substrate complexes
26. Ribozyme-mediated repair of defective mRNA by targeted trans-splicing
27. Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells
28. Revising messages traveling along the cellular information superhighway
29. Gene therapy's next wave: messenger RNA repair
30. Ribozyme-mediated repair of sickle β-globin mRNAs in erythrocyte precursors
31. Ribozyme-mediated trans-splicing of a trinucleotide repeat
32. Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts
33. Evaluating and enhancing ribozyme reaction efficiency in mammalian cells
34. Evaluating group I intron catalytic efficiency in mammalian cells
35. Self-splicing of the Tetrahymena intron from mRNA in mammalian cells
36. Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: more isn't always better
37. Catalysis of RNA cleavage by Tetrahymena thermophila ribozyme. 2. Kinetic description of the reaction of an RNA substrate that forms a mismatch at the active site
38. Optimizing the substrate specificity of a group I intron ribozyme
39. Alteration of substrate specificity for the endoribonucleolytic cleavage of RNA by the Tetrahymena ribozyme
40. Trans-splicing ribozymes for targeted gene delivery